参考文献/References:
[1] Daniel MC, Astruc D. Cold nanoparticles:assembly, supramolecu-lar chemistry, quantum-size-related properties, and applications to-ward biology, catalysis and nanotechnology. Chem Rev, 2004, 104(1):293-346.
[2] von Maltzahn G,Centrone A, Park JH, et al. SERS-coded gold nanorods as a multifunctional platform for densely multiplexed near-infrared imaging and photothermal heating. Adv Mater, 2009, 21(31):3175-3180.
[3] Huang X, Jain PK, El-Sayed IH,et al. Determination of the mini-mum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem Photobiol, 2006, 82(2):412-417.
[4] Huang X, El-Sayed IH, Qian W,et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc,2006, 128(6):2115-2120.
[5] Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell-models in vivo. Adv Drug Deliv Rev, 2004, 56(8):1085-1097.
[6] Sabharanjak S, Mayor S. Folate receptor endocytosis and traffick-ing. Adv Drug Deliv Rev, 2004, 56(8):1099-1109.
[7] Dixit V, Van den Bossche J, Sherman DM,et al. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparti-cles for selective targeting of folate receptor-positivey tumor cells. Bioconjug Chem, 2006, 17(3):603-609.
[8] Prabaharan M, trailer JJ, Pilla S, et al. Gold nanoparticles with amonolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials, 2009, 30(30):6065-6075.
[9] Tong L, Zhao Y, Huff TB,et al. Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv Mater, 2007, 19(20):3136-3141.
[10] Yang PH, Sun X, Chiu JF, et al. Transferrin-mediated gold nanoparticle cellular uptake.Bioconjug Chem, 2005, 16(3):494-496.
[11] Krause W. Delivery of diagnostic agents in computed tomography. Adv Drug Deliv Rev, 1999, 37(1-3):159-173.
[12] 范旭,郭志睿,曹敏,等.基于金纳米颗粒的CT造影剂.CT理论与应用研究,2009, 18(4):15-25.
[13] Raether H. Surface plasmons on smooth and rough surfaces and on gratings. Berlin:Spring-Verlag, 1988:37.
[14] Popovtzer R, Agrawal A, Kotov NA,et al. Targeted gold nanoparti-cles enable molecular CT imaging of cancer. Nano Lett, 2008, 8(12):4593-4596.
[15] Hainfeld JF, Slatkin DN, Focella TM, et al. Gold nanoparticles:A new X-ray contrast agent. Br J Radiol, 2006, 79(939):248-253.
[16] Cho WS, Kim S, Han BS,et al. Comparison of gene expression pro-files in mice liver following intravenous injection of 4 and 100nm-sized PEC-coated gold nanoparticles.Toxicol Lett, 2009, 191(1):96-102.
[17] 赵琢,王利兵,张园,等.纳米物质生物安全性研究进展.纳米科技,2008, 5(2):61-65.
[18] 叶娟平,刘韬,戴昆伦,等.放射增敏剂的临床研究进展.医药导报,2009, 28(7):893-896.
[19] Liu CJ, Wang CH, Chien CC,et al. Enhanced x-ray irradiation-induced cancer cell damage by gold nanoparticles treated by a new synthesis method of polyethylene glycol modification. Nanotech-nology, 2008, 19(29):95-104.
[20] Kong T, Zeng J, Wang XP,et al. Enhancement of radiation cytotoxi-city in breast-cancer cells by localized attachment of gold nanopar-ticles. Small, 2008, 9(4):1537-1543.
[21] Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparti-cles to enhance radiotherapy in mice.Phys Med Biol, 2004, 49(18):309-315.
[22] El-Sayed IH, Huang X, El-Sayed MA. Selective laser photohermal therapy of epithelial carcinoma using anti-EGFR antibody conju-ated gold nanoparticles. Cancer Lett, 2006, 239(1):129-135.
[23] Attix FH. Introduction to radiological physics and radiation dosimetry. New York:Wiley, 1991:124-159.
[24] Herold DM, Das IJ, Stobbe CC. Cold microspheres:a selective tech-nique for producing biologically effective dose enhancement. Int J Radiat Biol, 2000, 76(10):1357-1364.
[25] Nel A, Xia T, M dler L, Li N. Toxic potential of materials at the nanolevel. Science,2006, 311(5761):622-627.
[26] Turner J, Koumenis C, Kute TE,et al. Tachpvridine,a metal chela-tor, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation. Blood, 2005, 106(9):3191-3199.
[27] Loo C, Lowery A, Hulas N, et al. Immunotargeted nanoshells for Integrated cancer imaging and therapy. Nano Letters, 2005, 5(4):709-711.
[28] Lapotko D, Lukianova E, Potapnev M,et al. Method of laser acti-vated nano-thermolysis for elimination of tumor cell. Cancer Lett, 2006, 239(1):36-45.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[4]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[5]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[6]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[7]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[8]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[9]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[10]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[11]陆东燕,侯莎莎,丁恩慈,等.结核性与恶性腹膜弥漫性病变的18F-FDG PET/CT影像特征分析[J].国际放射医学核医学杂志,2014,38(6):398.[doi:10.3760/cma.j.issn.1673-4114.2014.06.012]
Lu Dong-yan,Hou Sha-sha,Ding En-ci,et al.Analysis of 18F-FDG PET/CT imaging features of tuberculous and cancerous diffuse peritoneal lesions[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):398.[doi:10.3760/cma.j.issn.1673-4114.2014.06.012]
[12]刘春利,李毅红.18F-FDG PET/CT在原发灶不明的脑转移瘤中的诊断价值[J].国际放射医学核医学杂志,2013,37(2):92.[doi:10.3760/cma.j.issn.1673-4114.2013.02.008]
LIU Chun-li,LI Yi-hong.The value of 18F-FDG PET/CT in diagnosing brain metastases from unknown primary tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):92.[doi:10.3760/cma.j.issn.1673-4114.2013.02.008]
[13]王胜军,杨卫东,赵小虎,等.18F-FDG PET/CT诊断多发癌的价值[J].国际放射医学核医学杂志,2013,37(2):96.[doi:10.3760/cma.j.issn.1673-4114.2013.02.009]
WANG Sheng-jun,YANG Wei-dong,ZHAO Xiao-hu,et al.Value of 18F-FDG PET/CT in the diagnosis of multiple primary malignant neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):96.[doi:10.3760/cma.j.issn.1673-4114.2013.02.009]
[14]唐宇辉,陈跃.PET/CT在儿科恶性肿瘤中的应用进展[J].国际放射医学核医学杂志,2013,37(2):107.[doi:10.3760/cma.j.issn.1673-4114.2013.02.012]
TANG Yu-hui,CHEN Yue.The progression of PET/CT in pediatric malignant tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):107.[doi:10.3760/cma.j.issn.1673-4114.2013.02.012]
[15]孙爱君,任茜,刘健,等.11C-乙酸盐PET和PET/CT在肿瘤显像中的应用[J].国际放射医学核医学杂志,2013,37(4):243.[doi:10.3760/cma.j.issn.1673-4114.2013.04.013]
SUN Ai-jun,REN Qian,LIU Jian,et al.The application of 11C-acetate PET and PET-CT for tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):243.[doi:10.3760/cma.j.issn.1673-4114.2013.04.013]
[16]辛军,赵周社,李红,等.自适应统计迭代重建技术在PET/CT全身扫描中的应用[J].国际放射医学核医学杂志,2013,37(5):279.[doi:10.3760/cma.j.issn.1673-4114.2013.05.007]
XIN Jun,ZHAO Zhou-she,LI Hong,et al.Adaptive statistical iterative reconstruction technology in the application of PET/CT whole body scans[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):279.[doi:10.3760/cma.j.issn.1673-4114.2013.05.007]
[17]汪会,徐慧琴.肿瘤乏氧显像剂的研究进展[J].国际放射医学核医学杂志,2012,36(6):366.[doi:10.3760/cma.j.issn.1673-4114.2012.06.011]
WANG Hui,XU Hui-qin.Advances in study of tumor hypoxia imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):366.[doi:10.3760/cma.j.issn.1673-4114.2012.06.011]
[18]汪太松,赵晋华,宋建华.PET-MRI和多模式肿瘤显像[J].国际放射医学核医学杂志,2011,35(5):261.[doi:10.3760/cma.j.issn.1673-4114.2011.05.002]
WANG Tai-song,ZHAO Jin-hua,SONG Jian-hua.PET-MRI and multimodal cancer imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):261.[doi:10.3760/cma.j.issn.1673-4114.2011.05.002]
[19]周敏,魏秋霞,林俊杰,等.良恶性肿瘤18F-FDG符合线路显像的临床价值[J].国际放射医学核医学杂志,2011,35(5):279.[doi:10.3760/cma.j.issn.1673-4114.2011.05.006]
ZHOU Min,WEI Qiu-xia,LIN Jun-jie,et al.18F-FDG coincidence imaging for the detection of benign and malignant neoplasm[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):279.[doi:10.3760/cma.j.issn.1673-4114.2011.05.006]
[20]王冬艳,苏成海.PET、PEP-CT与磁共振弥散加权成像在肿瘤诊断中的对比研究进展[J].国际放射医学核医学杂志,2011,35(6):339.[doi:10.3760,cma.j.issn.1673-4114.2011.06.005]
WANG Dong-yan,SU Cheng-hai.Progression of comparison study between PET or PET-CT and magnetic resonance diffusion-weighted imaging in the investigation of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):339.[doi:10.3760,cma.j.issn.1673-4114.2011.06.005]